With nine days to the Nov. 3 vote, the market has priced the shift selectively, and the gaps are where…
Verizon’s Turnaround Faces Its Toughest Exam Yet, and SpaceX Just Walked Into the Room
Verizon reports third-quarter 2026 earnings before the open Monday, October 26. Consensus sits at about $34.25 billion in revenue and…
Why wait 90 days if gold can pay you this Friday?
A note from our friends at Investors Alley(ad) Tim Plaehn here. Most dividend stocks only pay you once every three…
Your download link expires soon
October 25, 2026 Bonus Content: Lilly Earnings: Can Volume Keep Outrunning Price? A note from our friends at Profits Run(ad)…
Verizon Reports Monday. Two Questions Decide the Stock.
Subscriber gains look real, but SpaceX just added a risk bulls may be underweight.
American Tower Is the Better SpaceX Trade. Here Is Why.
Tower stocks surged Friday on SpaceX lease reports. Only one deserves to keep the gain.
Moderna Lost a Quarter of Its Value on Good Data
Analyst Targets TD Cowen: Hold, $90 target (raised from $40 on October 21) RBC Capital: Sector Perform, $130 target Goldman…
I’ve been waiting DECADES for this…
October 24, 2026 Bonus Content: Alnylam’s Huntington’s Drug Cut the Disease Protein 64%. What the Model Is Really Pricing. A…
The Man Who Called Trump’s 2016 Win says, “Beware November 3rd”
October 24, 2026 Bonus Content: Kering Falls 17% and Gucci’s Decline Is Getting Worse A note from our friends at…
Gilead’s $1.275 Billion Bet on a China IBD Pill: Too Bold?
Paying full price for a Phase 1 asset from Shanghai tests whether Gilead’s inflammation push is disciplined diversification or acquisitive…